Q32 Bio (QTTB) Cash from Operations (2017 - 2026)
Q32 Bio (QTTB) recorded quarterly Cash from Operations of 6343000.0 in Q1 2026, down 2.64% quarter-over-quarter from 6180000.0 in Q4 2025, and up 49.18% on a YoY basis from 4251829.98 in Q1 2025.
Q32 Bio (QTTB) Cash from Operations (2017 - 2026) Analysis & Trends
Q32 Bio's Cash from Operations history runs 10 years deep, the most recent figure standing at 6343000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 49.18% year-over-year to 6343000.0; the TTM figure through Mar 2026 stood at 27404000.0 (up 58.25% YoY), while the FY2025 annual figure was 33543000.0, up 50.46% from the prior year.
- Cash from Operations was 6343000.0 for Q1 2026 at Q32 Bio, down from 6180000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 15901000.0 in Q3 2023 to a low of 30846000.0 in Q2 2022.
- Historically, Cash from Operations has averaged 14114058.82 across 5 years, with a median of 12482000.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations soared 163.78% in 2023, then sank 222.77% in 2024.
- A 5-year view of Cash from Operations shows it stood at 27199000.0 in 2022, then jumped by 60.61% to 10715000.0 in 2023, then declined by 6.65% to 11428000.0 in 2024, then surged by 45.92% to 6180000.0 in 2025, then retreated by 2.64% to 6343000.0 in 2026.
- The last three Cash from Operations figures came in at 6343000.0 (Q1 2026), 6180000.0 (Q4 2025), and 4230000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | -6.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.34 Mn |
| Mar 31, 2026 | -6.34 Mn |
| Dec 31, 2025 | -6.18 Mn |
| Dec 31, 2025 | -6.18 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Jun 30, 2025 | -10.65 Mn |
| Jun 30, 2025 | -10.65 Mn |
| Mar 31, 2025 | -12.48 Mn |
| Mar 31, 2025 | -12.48 Mn |
| Dec 31, 2024 | -11.43 Mn |
| Dec 31, 2024 | -11.43 Mn |
| Sep 30, 2024 | -19.52 Mn |
| Sep 30, 2024 | -19.52 Mn |
| Jun 30, 2024 | -22.21 Mn |
| Jun 30, 2024 | -22.21 Mn |
| Mar 31, 2024 | -14.55 Mn |
| Mar 31, 2024 | -14.55 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Dec 31, 2023 | -10.72 Mn |